Warmuth Markus Insider Trades

Insider Trading History

Track insider trading activity for Warmuth Markus. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
President & CEO
Holding Value $6.59M 585,038 shares
Last Trade
Jul 16, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$220k 9,500 shares
$23.18
$11.26
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
President & CEO
Holding Value $6.7M 595,006 shares
Last Trade
Jun 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$106k 5,466 shares
$19.44
$11.26
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
President & CEO
Holding Value $6.76M 600,004 shares
Last Trade
May 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$103k 5,467 shares
$18.92
$11.26
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
President & CEO
Holding Value $6.82M 605,471 shares
Last Trade
Apr 14, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$141k 8,000 shares
$17.64
$11.26
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
President & CEO
Holding Value $6.91M 613,471 shares
Last Trade
Mar 02, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$98k 5,466 shares
$17.92
$11.26
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
President & CEO
Holding Value $6.99M 620,696 shares
Last Trade
Jan 07, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$128k 5,466 shares
$23.49
$11.26
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
President & CEO
Holding Value $7.03M 624,403 shares
Last Trade
Jan 05, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$154k 10,135 shares
$15.17
$11.26
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
President & CEO
Holding Value $7.14M 634,538 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.59M 496,000 shares
$15.31
$11.26
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
President & CEO
Holding Value $6.47M 575,000 shares
Last Trade
Jan 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.09M 575,000 shares
$7.11
$11.26
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
President & CEO
Holding Value $3.9M 346,000 shares
Last Trade
Jan 02, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.98M 346,000 shares
$5.71
$11.26
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
President & CEO
Holding Value $5.31M 472,000 shares
Last Trade
Jan 03, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.67M 472,000 shares
$7.78
$11.26
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
President & CEO
Holding Value $3.55M 315,600 shares
Last Trade
Mar 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.23M 315,600 shares
$13.41
$11.26
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
See Remarks
Holding Value $1.59M 141,623 shares
Last Trade
Jun 23, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$11.26
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
See Remarks
Holding Value $4.69M 416,538 shares
Last Trade
Jun 23, 2021 Sale
No data
No data
$11.26
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
See Remarks
Holding Value $6.06M 538,517 shares
Last Trade
Apr 12, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$11.26

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up